Delivery Order SPE2DB22D1017-SPE2DB25FF3XJ
Award Date
1/24/25
Potential Completion Date
1/27/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
This federal contract award, valued at $1,784.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a period of performance through September 26, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $33,681.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 31, 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract...
This federal contract award, valued at $93,280.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron oral disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside....
This federal contract award, valued at $33,760.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,149,261 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $11,368.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,436 units of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $39,393.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $7,204.96 Firm Fixed Price delivery order covers the supply of 4,566,570,536 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,712.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,510,655 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,602.15 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...